Gudiksen Mark, Fleming Edd, Furstenthal Laura, Ma Philip
McKinsey & Company, 3075A Hansen Way, Palo Alto, California 94304, USA.
Nat Rev Drug Discov. 2008 Jul;7(7):563-7. doi: 10.1038/nrd2594. Epub 2008 Jun 6.
Specialty pharmaceuticals have become increasingly important in the global pharmaceutical landscape. Numerous large pharmaceutical companies are moving towards developing therapies for specialty markets, which are attractive owing to factors including the established commercial track record and lower commercial infrastructure costs. In this article, we analyse the key drivers of commercial success and failure for specialty pharmaceuticals.
专科药物在全球制药格局中变得越来越重要。许多大型制药公司正朝着开发针对专科市场的疗法迈进，这些市场因既有商业记录和较低的商业基础设施成本等因素而颇具吸引力。在本文中，我们分析了专科药物商业成功与失败的关键驱动因素。
